Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.

Cui H, Gao H, Cui X, Zhao Y, Shi X, Li Q, Yan S, Gao M, Wang M, Liu C, Wang Y.

PLoS One. 2013;8(1):e53340. doi: 10.1371/journal.pone.0053340. Epub 2013 Jan 3.

2.

Expression of HA of HPAI H5N1 virus at US2 gene insertion site of turkey herpesvirus induced better protection than that at US10 gene insertion site.

Gao H, Cui H, Cui X, Shi X, Zhao Y, Zhao X, Quan Y, Yan S, Zeng W, Wang Y.

PLoS One. 2011;6(7):e22549. doi: 10.1371/journal.pone.0022549. Epub 2011 Jul 27.

3.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

4.

Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.

Liu S, Sun W, Chu J, Huang X, Wu Z, Yan M, Zhang Q, Zhao P, Igietseme JU, Black CM, He C, Li Y.

PLoS One. 2015 Apr 20;10(4):e0124992. doi: 10.1371/journal.pone.0124992. eCollection 2015.

5.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
6.
7.

Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.

Gimeno IM, Cortes AL, Faiz NM, Hernandez-Ortiz BA, Guy JS, Hunt HD, Silva RF.

Avian Dis. 2015 Jun;59(2):255-62. doi: 10.1637/10966-103014-Reg.

PMID:
26473676
8.

Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.

Li Y, Reddy K, Reid SM, Cox WJ, Brown IH, Britton P, Nair V, Iqbal M.

Vaccine. 2011 Oct 26;29(46):8257-66. doi: 10.1016/j.vaccine.2011.08.115. Epub 2011 Sep 9.

PMID:
21907750
10.

Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains.

Soejoedono RD, Murtini S, Palya V, Felföldi B, Mató T, Gardin Y.

Avian Dis. 2012 Dec;56(4 Suppl):923-7.

PMID:
23402113
11.

Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).

Pantin-Jackwood MJ, Kapczynski DR, DeJesus E, Costa-Hurtado M, Dauphin G, Tripodi A, Dunn JR, Swayne DE.

Avian Dis. 2016 Mar;60(1):22-32. doi: 10.1637/11282-091615-Reg.1.

PMID:
26953940
12.

Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.

Pavlova SP, Veits J, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Aug 13;27(37):5085-90. doi: 10.1016/j.vaccine.2009.06.048. Epub 2009 Jun 30.

PMID:
19573638
13.

Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.

Reddy SK, Sharma JM, Ahmad J, Reddy DN, McMillen JK, Cook SM, Wild MA, Schwartz RD.

Vaccine. 1996 Apr;14(6):469-77.

PMID:
8782342
14.

Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.

Haq K, Elawadli I, Parvizi P, Mallick AI, Behboudi S, Sharif S.

Antiviral Res. 2011 Jun;90(3):218-26. doi: 10.1016/j.antiviral.2011.04.001. Epub 2011 Apr 8.

PMID:
21501630
15.

Construction of recombinant Marek's disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters.

Zhang Z, Chen W, Ma C, Zhao P, Duan L, Zhang F, Sun A, Li Y, Su H, Li S, Cui H, Cui Z.

J Biotechnol. 2014 Jul 10;181:45-54. doi: 10.1016/j.jbiotec.2014.03.032. Epub 2014 Apr 4.

PMID:
24709399
16.

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H.

J Virol. 2007 Jan;81(1):150-8. Epub 2006 Oct 18.

17.

Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer-Luijtze EA, van Zoelen-Bos DJ, Rigter A, Rottier PJ, Moormann RJ, de Haan CA.

PLoS One. 2012;7(8):e44447. doi: 10.1371/journal.pone.0044447. Epub 2012 Aug 28.

18.

Avian influenza adenovirus-vectored in ovo vaccination: target embryo tissues and combination with Marek's disease vaccine.

Breedlove C, Minc JK, Tang DC, van Santen VL, van Ginkel FW, Toro H.

Avian Dis. 2011 Dec;55(4):667-73.

PMID:
22312988
19.

Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses.

Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, Ahmed LE, Earhart KC, Perez DR, Collins PL, Samal SK.

PLoS One. 2009 Aug 5;4(8):e6509. doi: 10.1371/journal.pone.0006509.

20.

Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.

Nazerian K, Witter RL, Lee LF, Yanagida N.

Avian Dis. 1996 Apr-Jun;40(2):368-76.

PMID:
8790888

Supplemental Content

Support Center